ketoconazole has been researched along with nystatin a1 in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (29.82) | 18.7374 |
1990's | 30 (26.32) | 18.2507 |
2000's | 31 (27.19) | 29.6817 |
2010's | 16 (14.04) | 24.3611 |
2020's | 3 (2.63) | 2.80 |
Authors | Studies |
---|---|
Wang, SQ; Wang, YF; Xu, Z | 1 |
Andrade, JT; Antunes Fernandes, SO; Araújo, LA; Cardoso, VN; Johann, S; Lima, WG; Morais, FB; Prates Silva, MK; Ribeiro Viana, GH; Saldanha, AA; Siqueira Ferreira, JM; Soares, AC; Sousa, JF | 1 |
Buarque De Gusmao, N; Guiraud, P; Seigle-Murandi, F; Steiman, R | 1 |
Berlinck, RG; Kossuga, MH; MacMillan, JB; Molinski, TF; Nascimento, GG; Rocha, RM; Rogers, EW | 1 |
Avery, T; Greatrex, B; Macreadie, I; Macreadie, P; Taylor, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Avery, TD; Greatrex, BW; Macreadie, IG; Macreadie, PI; Robinson, TV; Taylor, DK | 1 |
Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
Aghatabay, NM; Dülger, B; Haciu, D; Karabiyik, T; Neshat, A; Somer, M | 1 |
Aghatabay, NM; Dulger, B; Gucin, F; Senel, M; Somer, M | 1 |
Deising, HB; Serfling, A; Wohlrab, J | 1 |
Aghatabay, NM; Cevik, H; Dulger, B; Mahmiani, Y | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ | 1 |
Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Aghatabay, NM; Baş, A; Dülger, B; Gücin, F; Kircali, A; Sen, G; Yazicioğlu, MB | 1 |
Alves, AJ; Alves, AQ; Alves, EW; Carvalho, CS; de Aquino, TM; de Araújo, JM; de Faria, AR; de Lima, JG; de Melo, EJ; Góes, AJ; Liesen, AP; Lima, VT | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
Agabian, N; Greenspan, D; Greenspan, JS; Hicks, JB; MacPhail, LA; Miyasaki, SH; Polacheck, I; White, TC | 1 |
Fotos, PG; Hellstein, JW; Vincent, SD | 1 |
Kimputu, L; Lumbila, M; Nelson, AM; Nyst, MJ; Perriens, JH; Piot, P | 1 |
Bullock, WE; Gootee, L; Morris, R; Newman, SL | 1 |
Hendriks, WD; Sizoo, W; Thunnissen, PL | 1 |
Bard, M; Broughton, MC; Lees, ND; Sanglard, D | 1 |
Pariser, DM | 1 |
Kitazawa, K; Nakade, T; Uchida, Y | 1 |
Connors, JM; Klimo, P; Turhan, A | 1 |
Farid, A; Makarem, MH; Sabra, AM; Salah, M; Salem, HT | 1 |
Ciancio, SG | 1 |
Bagan Sebastián, JV; Ramón Muñiz, J; Tejerina Lobo, JM | 1 |
Boon, JM; Lafeber, HN; Mannetje, AH; Smeets, HL; Toorman, J; van der Vlist, GJ; van Olphen, AH | 1 |
Abarca, L; Bragulat, M; Bruguera, T; Cabañes, FJ | 1 |
Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
Cavanna, C; Garavelli, PL; Maccabruni, A; Michelone, G | 1 |
Davis, CP; Gudewicz, TM; Mader, JT | 1 |
Hay, RJ | 1 |
Bingham, JS | 1 |
Galbraith, GM; Holley, HP; Lee, WM; Stewart, J | 1 |
Brenciaglia, MI; Cipriani, P; Ghezzi, MC; Mancini, C; Trancassini, M | 1 |
Cauwenbergh, G | 1 |
Malcom, LG; Vogler, WR; Winton, EF | 1 |
Ito, A | 1 |
De Bernardis, F; Lorenzini, R; Mercantini, R | 1 |
Hammerschlag, MR; Rao, SP; Walk, JA | 1 |
Quinn, DM | 1 |
Berkowitz, RJ; Cheung, NK; Coccia, PF; Gordon, EM; Hughes, C; Rudnick, M; Strandjord, S; Warkentin, P | 1 |
Klosterman, A; Meyers, JD; Shepp, DH; Siegel, MS | 1 |
Haas, A; Stiehm, ER | 1 |
Hamácek, F; Otcenásek, M; Vejbora, O | 1 |
Blacklock, HA; Boesen, E; Corringham, R; Fox, J; Gascoigne, E; Hann, IM; Hoffbrand, AV; Keaney, M; Noone, P; Prentice, HG; Shannon, M; Szawatkowski, M | 1 |
Högl, F; Raab, W | 1 |
Chretien, JH; Garagusi, VF | 1 |
Young, LS | 1 |
Brajtburg, J; Kobayashi, D; Kobayashi, GS; Medoff, G | 1 |
Bastide, JM; Bastide, M; Jouvert, S | 1 |
Meunier-Carpentier, F | 2 |
Bergman, AG; Jones, PG; Kauffman, CA; Liepman, MK; McAuliffe, LS | 2 |
García-Pérez, A; Gómez de la Concha, E; Guerra Rodríguez, P | 1 |
Aly, Z; Speight, PM; Zakrzewska, JM | 1 |
Clermónt, MJ; Hébert, E; Mérouani, A; Robitaille, P | 1 |
Greenspan, D | 1 |
Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
Goodwin, SD; Grasela, TH; Pasko, MT; Raebel, MA; Walawander, CA | 1 |
Agarwal, N; Austria, L; Cerabona, T; Policastro, A; Savino, JA; Wry, P | 1 |
Johnson, EM; Warnock, DW; White, DJ | 1 |
Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Smith, JG | 1 |
Bahukova, TA; Dobrodeeva, LK | 1 |
Evans, S; Leake, H; Ustianowski, AP | 1 |
Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
Burgaleta, C | 1 |
Ellepola, AN; Samaranayake, LP | 6 |
Aoussi, E; Arnavielhe, S; Bastide, JM; Combe, P; Kacou, A; Koné, M; Le Guennec, R; Mallié, M; Ménan, E; Nébavi, F | 1 |
Daza, RM; Martín, JE; Martín, P; Martínez, MM; Mendaza, P; Portero, F; Sánchez, G | 1 |
Bonito, AJ; Patton, LL; Shugars, DA | 1 |
Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
Bozhkova, K; Vasileva, P | 1 |
Azcurra, A; Battellino, LJ; Calamari, S; Cornejo, LS; Dorronsoro de Cattoni, ST; Femopase, F; López de Blanc, S | 1 |
Marrazzo, J | 2 |
Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
Spence, D | 2 |
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
Akdeniz, BG; Ates, M; Sen, BH | 1 |
Baba, E; Nakano, Y; Sasai, K; Tani, H; Wada, M | 1 |
Chen, FC; Lin, M | 1 |
Chukwuneke, F; Oji, C | 1 |
Arrais, CA; Giannini, M; Seó, RS; Urban, VM | 1 |
Jayatilake, JA; Samaranayake, LP; Samaranayake, YH; Thein, ZM; Yau, JY; Yeung, KW | 1 |
Jornet-García, V; López-Jornet, P; Martínez-Beneyto, Y; Velandrino-Nicolás, A | 1 |
Barbério, GS; Bueno, MG; da Silva, WJ; Neppelenbroek, KH; Pinto, L; Porto, VC; Urban, VM | 1 |
Arioli Filho, JN; Bueno, MG; de Almeida, AL; Giannini, M; Lima, TF; Neppelenbroek, KH; Urban, VM | 1 |
Bandara, HM; Ellepola, AN; Joseph, BK; Khan, ZU; Samaranayake, LP | 1 |
Ellepola, AN; Jayathilake, JA; Khan, ZU; Sharma, PN | 1 |
Cral, WG; Hotta, J; Lara, VS; Neppelenbroek, KH; Sakima, VT; Urban, VM | 1 |
Almeida, ALPF; Galitesi, LL; Hotta, J; Lima, JFM; Neppelenbroek, KH; Urban, VM | 1 |
Cestari, TM; Garlet, GP; Hotta, J; Lima, JFM; Neppelenbroek, KH; Porto, VC; Urban, VM | 1 |
Hay, RJ; Jemec, GBE; Saunte, DML; Taudorf, EH | 1 |
Butler, G; de San Vicente, KM; Iracane, E; Lombardi, L; Schröder, MS | 1 |
Farago, PV; MichÉl, MD; Neppelenbroek, KH; SÁnchez-Aliaga, A; Sugio, CYC; Urban, VM | 1 |
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
16 review(s) available for ketoconazole and nystatin a1
Article | Year |
---|---|
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
Topics: Amphotericin B; Drug Administration Schedule; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mycoses; Nystatin | 1986 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; Paracoccidioidomycosis; Piperazines; Sulfadiazine | 1982 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin | 1984 |
Treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Clotrimazole; Fluconazole; HIV Infections; Humans; Ketoconazole; Leukocyte Count; Nystatin; Risk Factors | 1994 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Itraconazole; Ketoconazole; Nystatin; Recurrence; Sexual Partners | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Sexual Partners | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Secondary Prevention; Sexual Partners | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Nystatin; Secondary Prevention | 2005 |
Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Clotrimazole; Drug Therapy, Combination; Evidence-Based Medicine; Fluconazole; Humans; Ketoconazole; Miconazole; Nystatin | 2019 |
14 trial(s) available for ketoconazole and nystatin a1
Article | Year |
---|---|
Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Democratic Republic of the Congo; Female; Gentian Violet; Humans; Ketoconazole; Male; Nystatin | 1992 |
Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ketoconazole; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycoses; Nystatin; Prednisone; Prospective Studies; Random Allocation; Time Factors; Vincristine | 1987 |
Oral versus local treatment of vaginal candidosis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Middle Aged; Nystatin; Pessaries; Random Allocation; Recurrence | 1989 |
A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Candidiasis, Oral; Female; Humans; Immune Tolerance; Ketoconazole; Leukemia; Male; Middle Aged; Neutropenia; Nystatin; Random Allocation | 1987 |
Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
Topics: Agranulocytosis; Candida albicans; Candidiasis; Clinical Trials as Topic; Environment, Controlled; Humans; Ketoconazole; Mycoses; Neutropenia; Nystatin; Patient Compliance; Random Allocation | 1985 |
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
Topics: Amphotericin B; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Imidazoles; Immunosuppressive Agents; Ketoconazole; Leukemia; Mycoses; Neutropenia; Nystatin; Piperazines; Random Allocation | 1982 |
Prophylaxis of fungal infections in neutropenic cancer patients.
Topics: Agranulocytosis; Amphotericin B; Aspergillosis; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Neoplasms; Neutropenia; Nystatin; Patient Isolation | 1983 |
Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
Topics: Adult; Agranulocytosis; Female; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Neutropenia; Nystatin; Prospective Studies; Random Allocation | 1984 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin | 1984 |
Effect of prophylactic ketoconazole and nystatin on fungal flora.
Topics: Adolescent; Adult; Clinical Trials as Topic; Humans; Ketoconazole; Leukemia; Lymphoma; Mycoses; Nystatin; Oropharynx; Species Specificity; Yeasts | 1984 |
Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients.
Topics: Aged; Candida; Candidiasis; Clotrimazole; Colony Count, Microbial; Critical Illness; Cross Infection; Female; Fungemia; Humans; Incidence; Intensive Care Units; Ketoconazole; Length of Stay; Logistic Models; Male; Middle Aged; Multiple Trauma; Nystatin; Postoperative Complications; Premedication; Prospective Studies; Risk Factors; Severity of Illness Index | 1994 |
Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cote d'Ivoire; Drug Resistance, Microbial; Fungal Proteins; Genetic Variation; Humans; Ketoconazole; Middle Aged; Nystatin; Phylogeny; Treatment Outcome | 1998 |
Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Humans; Iron; Ketoconazole; Male; Middle Aged; Mouth Mucosa; Nystatin; Peroxidase; Protein Binding; Saliva; Thiocyanates; Treatment Outcome | 1998 |
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; CD4 Lymphocyte Count; Female; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Ketoconazole; Male; Middle Aged; Mouthwashes; Nystatin; Treatment Outcome | 2008 |
85 other study(ies) available for ketoconazole and nystatin a1
Article | Year |
---|---|
Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp.
Topics: Alkaloids; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Drug Design; Fungicides, Industrial; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Antimicrobial and antitumor activities of mycosporulone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cyclohexanes; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Spiro Compounds; Tumor Cells, Cultured | 1999 |
(2S,3R)-2-aminododecan-3-ol, a new antifungal agent from the ascidian Clavelina oblonga.
Topics: Animals; Antifungal Agents; Brazil; Candida; Circular Dichroism; Dodecanol; Molecular Structure; Stereoisomerism; Urochordata | 2004 |
Novel endoperoxides: synthesis and activity against Candida species.
Topics: Candida; Microbial Sensitivity Tests; Molecular Conformation; Peroxides; Species Specificity; Stereoisomerism | 2006 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Design of endoperoxides with anti-Candida activity.
Topics: Animals; Antifungal Agents; Candida albicans; Cell Proliferation; CHO Cells; Cricetinae; Drug Design; Erythrocytes; Humans; Microbial Sensitivity Tests; Molecular Conformation; Peroxides; Stereoisomerism; Structure-Activity Relationship | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cadmium; Chelating Agents; Disk Diffusion Antimicrobial Tests; Ferrous Compounds; Ligands; Magnetic Resonance Spectroscopy; Metals, Heavy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organomercury Compounds; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Zinc | 2007 |
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
Topics: Anti-Infective Agents; Bacteria; Disk Diffusion Antimicrobial Tests; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Palladium; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman; Yeasts | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
Topics: Anti-Infective Agents; Aza Compounds; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman | 2009 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Apoptosis; Bacteria; Cattle; Cell Line, Tumor; DNA; Humans; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Yeasts | 2009 |
Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Bacteria; Chlorocebus aethiops; Drug Resistance; Fungi; Intracellular Space; Microbial Sensitivity Tests; Semicarbazides; Thiazolidines; Toxoplasma; Vero Cells | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals.
Topics: AIDS-Related Opportunistic Infections; Blotting, Southern; Candida albicans; Candidiasis; DNA, Fungal; Female; Genome, Fungal; HIV Seropositivity; Homosexuality; Humans; Ketoconazole; Male; Mouth; Nystatin; Polymorphism, Genetic | 1992 |
Oral candidosis. Clinical, historical, and therapeutic features of 100 cases.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Female; Humans; Ketoconazole; Male; Middle Aged; Mouthwashes; Nystatin | 1992 |
Digestion of Histoplasma capsulatum yeasts by human macrophages.
Topics: Cells, Cultured; Chloroquine; Histoplasma; Humans; Ketoconazole; Macrophages; Nystatin; Phagocytosis | 1992 |
Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Neutropenia; Nystatin; Prospective Studies | 1991 |
Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.
Topics: Azoles; Candida albicans; Clotrimazole; Cytochrome P-450 Enzyme System; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mutation; Nystatin | 1990 |
Cutaneous candidiasis. A practical guide for primary care physicians.
Topics: Administration, Cutaneous; Administration, Oral; Candida; Candidiasis, Cutaneous; Humans; Ketoconazole; Nail Diseases; Nystatin; Physicians, Family; Skin | 1990 |
In vitro activity of five antifungal agents against Malassezia pachydermatis.
Topics: Animals; Antifungal Agents; Clotrimazole; Dog Diseases; Dogs; Humans; Ketoconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Otitis Externa | 1990 |
Antifungal agents.
Topics: Antifungal Agents; Clotrimazole; Dental Care; Humans; Ketoconazole; Miconazole; Nystatin | 1989 |
[Stomatitis from dentures: etiopathological and therapeutic considerations].
Topics: Candidiasis, Oral; Chlorhexidine; Denture, Complete; Humans; Ketoconazole; Nystatin; Oral Hygiene; Stomatitis; Stomatitis, Denture | 1989 |
Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis.
Topics: Candidiasis, Oral; Child, Preschool; Humans; Infant; Infant, Newborn; Ketoconazole; Nystatin; Suspensions | 1989 |
Sensitivity of some strains of the genus Epidermophyton to different antifungal agents.
Topics: Antifungal Agents; Clotrimazole; Econazole; Epidermophyton; Griseofulvin; Imidazoles; Ketoconazole; Miconazole; Natamycin; Nystatin | 1989 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Microbial; Female; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Male; Miconazole; Nystatin | 1988 |
Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Hyperbaric Oxygenation; Ketoconazole; Miconazole; Nystatin; Time Factors | 1987 |
The current status of antimycotics in the treatment of local mycoses.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Benzoates; Dermatomycoses; Drug Combinations; Etretinate; Female; Griseofulvin; Humans; Imidazoles; Ketoconazole; Nystatin; Potassium Permanganate; Resorcinols; Salicylates; Salicylic Acid; Suppositories; Tretinoin; Vagina | 1986 |
Vulvo-vaginal candidosis--an overview.
Topics: Candidiasis, Vulvovaginal; Coitus; Diabetes Complications; England; Epidemiologic Methods; Female; Humans; Ketoconazole; Male; Nystatin; Penis; Time Factors; Vagina; Vaginitis; Vulvitis | 1986 |
Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.
Topics: Adult; Candidiasis; Esophageal Diseases; Female; Humans; Immunologic Deficiency Syndromes; Interleukin-2; Ketoconazole; Lymphokines; Molecular Weight; Nystatin; Rosette Formation; T-Lymphocytes | 1986 |
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response Relationship, Drug; Epithelium; Flucytosine; Humans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Time Factors | 1986 |
[Progress in chemotherapeutic agents--antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Ketoconazole; Nystatin | 1986 |
In vitro sensitivity of Malassezia spp. to various antimycotics.
Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Dog Diseases; Dogs; Econazole; Humans; Ketoconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Nystatin; Otitis; Tinea Versicolor | 1985 |
Candida esophagitis in two children with acute leukemia: successful therapy with ketoconazole.
Topics: Amphotericin B; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Esophagitis; Female; Humans; Ketoconazole; Leukemia, Lymphoid; Male; Nystatin; Thrombocytopenia | 1985 |
The effectiveness, in vitro, of miconazole and ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans.
Topics: Acrylic Resins; Amphotericin B; Candida albicans; Fentanyl; Isothiocyanates; Ketoconazole; Methylmethacrylates; Miconazole; Nystatin; Phthalic Acids; Tissue Conditioning, Dental | 1985 |
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Burkitt Lymphoma; Candidiasis; Child; Child, Preschool; Female; Humans; Infant; Ketoconazole; Leukemia; Leukemia, Lymphoid; Male; Mouth Diseases; Neuroblastoma; Nystatin; Pharyngeal Diseases; Povidone-Iodine; Transplantation, Autologous; Transplantation, Homologous | 1985 |
The "yeast connection" meets chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Humans; Ketoconazole; Male; Nystatin | 1986 |
[Sensitivity of yeast-like organisms to representatives of polyene antibiotics and imidazole chemotherapeutic agents in vitro].
Topics: Antifungal Agents; Ketoconazole; Miconazole; Natamycin; Nystatin; Yeasts | 1983 |
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae | 1981 |
The outlook for antifungal prophylaxis in the compromised host.
Topics: Candidiasis; Humans; Imidazoles; Immunity; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; Piperazines | 1982 |
Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida albicans; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Filipin; Humans; Imidazoles; Ketoconazole; Lucensomycin; Miconazole; Nystatin; Piperazines; Serum Albumin; Time Factors | 1982 |
A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cell Membrane; Cell Wall; Clotrimazole; Econazole; Imidazoles; Ketoconazole; Miconazole; Microscopy, Electron, Scanning; Nystatin; Piperazines | 1982 |
[Familial chronic mucocutaneous candidiasis. Study of 2 families].
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Consanguinity; Female; Humans; Ketoconazole; Male; Nystatin; Pedigree | 1984 |
Oral hairy leukoplakia in a HIV-negative asthmatic patient on systemic steroids.
Topics: Antifungal Agents; Asthma; Betamethasone; Candidiasis, Oral; HIV Seronegativity; Humans; Ketoconazole; Leukoplakia, Hairy; Male; Middle Aged; Nystatin | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience.
Topics: Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Child; Gastrostomy; Humans; Jejunostomy; Ketoconazole; Nystatin; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Risk Factors; Uremia | 1995 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Utilization; Hospitals; Humans; Ketoconazole; Mycoses; Nystatin; Prospective Studies; Risk Factors; United States | 1994 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin | 1993 |
New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; CD4-Positive T-Lymphocytes; Digestive System; Disease Models, Animal; Female; Fluconazole; Ketoconazole; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Nystatin; Oropharynx; Peptides; Peptides, Cyclic | 1996 |
[Role of fungi belonging to the genus Candida in the etiology of nonspecific pulmonary diseases].
Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Antifungal Agents; Candicidin; Candida; Humans; Ketoconazole; Lung Diseases, Fungal; Microbial Sensitivity Tests; Middle Aged; Nystatin; Retrospective Studies; Sputum | 1996 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin | 1998 |
[Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Econazole; Flucytosine; Ketoconazole; Miconazole; Nystatin; Saccharomyces cerevisiae; Yeasts | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
[Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Bulgaria; Candidiasis, Vulvovaginal; Child; Child, Preschool; Clotrimazole; Female; Humans; Infant; Ketoconazole; Nystatin; Treatment Outcome | 2001 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
The effect of calcium chelating or binding agents on Candida albicans.
Topics: Analysis of Variance; Antifungal Agents; Calcium; Candida albicans; Chelating Agents; Edetic Acid; Egtazic Acid; Fluorides; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Root Canal Irrigants; Sodium Fluoride; Statistics, Nonparametric; Titanium | 2005 |
Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Drug Resistance, Fungal; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Monoterpenes; Naphthalenes; Nystatin; Otitis Externa; Species Specificity; Terbinafine; Tropolone | 2005 |
[Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Nystatin; Saccharomyces | 2007 |
Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study.
Topics: Antifungal Agents; Crystallization; Dental Materials; Denture Liners; Dose-Response Relationship, Drug; Drug Delivery Systems; Ketoconazole; Miconazole; Microscopy, Electron, Scanning; Nystatin; Polymers; Polymethacrylic Acids; Spectrometry, X-Ray Emission; Tissue Conditioning, Dental | 2009 |
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; Cell Wall; Epithelial Cells; Flucytosine; Humans; Hydrophobic and Hydrophilic Interactions; Ketoconazole; Nephelometry and Turbidimetry; Nystatin | 2010 |
Use of antifungal agents for oral candidiasis: results of a national survey.
Topics: Administration, Topical; Adult; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Oral; Clotrimazole; Dentists; Female; General Practice, Dental; Humans; Ketoconazole; Male; Miconazole; Nystatin; Oral Medicine; Private Practice; Professional Practice; Public Health Dentistry; Sex Factors; Spain; Stomatitis, Denture; Surveys and Questionnaires; Time Factors | 2010 |
Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Denture Liners; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin | 2015 |
Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials.
Topics: Anti-Infective Agents; Chlorhexidine; Denture Liners; Hardness; Itraconazole; Ketoconazole; Materials Testing; Miconazole; Nystatin; Polymethacrylic Acids; Surface Properties | 2015 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin | 2016 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocandins; Fluconazole; Hemolysin Proteins; Humans; Ketoconazole; Kuwait; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Sri Lanka; Time Factors | 2016 |
Intraoral Device for Optimal Antifungal Delivery in a Rat Model.
Topics: Administration, Oral; Animals; Antifungal Agents; Chlorhexidine; Denture Liners; Ketoconazole; Nystatin; Rats; Rats, Wistar | 2017 |
Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Denture Liners; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Tensile Strength | 2018 |
In vivo biocompatibility of an interim denture resilient liner containing antifungal drugs.
Topics: Acrylic Resins; Analysis of Variance; Animals; Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Denture Liners; Keratins; Ketoconazole; Materials Testing; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin; Rats; Rats, Wistar | 2019 |
Correlating Genotype and Phenotype in the Asexual Yeast
Topics: Animals; Antifungal Agents; Caffeine; Candida parapsilosis; Codon, Terminator; CRISPR-Cas Systems; Fungal Proteins; Genotype; Ketoconazole; Lepidoptera; Microbial Sensitivity Tests; Microorganisms, Genetically-Modified; Nystatin; Phenotype; Polymorphism, Single Nucleotide; Virulence | 2019 |
Surface morphology and in vitro leachability of soft liners modified by the incorporation of antifungals for denture stomatitis treatment.
Topics: Antifungal Agents; Candida albicans; Denture Liners; Humans; Ketoconazole; Materials Testing; Nystatin; Stomatitis, Denture; Surface Properties | 2021 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |